Tüberküloza İkincil Addison Hastalığı

Abstract

Giriş: Addison hastalığı adrenal bez hormon üretiminde eksiklikler sonucu görülen, nadir ancak tedavisiz bırakıldığı takdirde ölümcül olabilen bir hastalıktır. Bu yazıda, 21 yaşında başağrısı ve halsizlik şikayeti ile acil servise başvuran ve sonrasında Addison hastalığı tanısı konulan bir hasta sunuldu. Olgu Sunumu: Hastanın ilk muayenesinde vital bulguları stabil ve hayati tehdit oluşturan bir semptomu bulunmamaktaydı. Hastanın takipleri esnasında gelişen kalp ve solunum durması başarılı bir şekilde yönetildi ve elektrolit bozukluğu düzeltildi. Sonuç: Addison hastalığı halsizlik şikayeti ile başvuran ve elektrolit bozukluğu bulunan hastaların ayırıcı tanısında düşünülmelidir.

Keywords

• Addison hastalığı, hiperkalemi, tüberküloz

Addison’s Disease Secondary to Tuberculosis

Abstract

Introduction: Addison’s disease occurs as a result of the lack of production of adrenocortical hormones, which is a rare but fatal disease if left untreated. In this paper, a case of a 21-year old patient admitted to the emergency department with compaints of weakness and headache, and subsequently diagnosed as Addison’s disease is presented.Case Report: On admission, the patient’s vital signs were stable and there were no life-threatening symptoms. A cardiac and respiratory arrest developed in the patient during follow-up and was successfully managed with electrolyte abnormalities correction.Conclusion: Addison’s disease should be considered in the differential diagnosis of patients who complain of fatigue with electrolyte disturbance

Keywords

• Addison’s disease, hyperkalemia, tuberculosis

References

1. Kong MF, Jeffcoate W. Eighty-six cases of Addison’s disease. Clin Endo- crinol (Oxf ) 1994; 41: 757-61. [CrossRef]
2. Willis AC, Vince FP. The prevalence of Addison’s disease in Coventry, UK. Postgrad Med J 1997; 73: 286-88. [CrossRef]
3. Regal M, Paramo C, Sierra SM, Garcia-Mayor RV. Prevalence and inci- dence of hypopituitarism in an adult Caucasian population in north- western Spain. Clin Endocrinol (Oxf ) 2001; 55: 735-40. [CrossRef]
4. Nomura K, Demura H, Saruta T. Addison’s disease in Japan: Characteris- tics and changes revealed in a nationwide survey. Intern Med 1994; 33: 602-6. [CrossRef]
5. Soule S. Addison’s disease in Africa: A teaching hospital experience. Clin Endocrinol (Oxf ) 1999; 50: 115-20. [CrossRef]
6. Lam KY, Lo CY. A critical examination of adrenal tuberculosis and a 28- year autopsy experience of active tuberculosis. Clin Endocrinol (Oxf ) 2001; 54: 633-9. [CrossRef]
7. Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335: 1206-12. [CrossRef]
8. Lovas K, Husebye ES. High prevalence and increasing incidence of Ad- dison’s disease in western Norway. Clin Endocrinol (Oxf) 2002; 56: 787-91. [CrossRef]

9. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G. Pre- mature mortality in patients with Addison’s disease: a population based study. J Clin Endocrinol Metab 2006; 91: 4849-53. 9